143 related articles for article (PubMed ID: 6763791)
1. Recent results on the pathogenesis of hepatitis B and characterization of the agent.
Roggendorf M; Deinhardt F
Triangle; 1982; 21(4):123-31. PubMed ID: 6763791
[No Abstract] [Full Text] [Related]
2. [Serologic markers of hepatitis B virus. Recent progress].
Mora Pérez I; Porres Cubero JC; Carreño García V
Rev Clin Esp; 1984 Apr; 173(1):9-14. PubMed ID: 6330799
[No Abstract] [Full Text] [Related]
3. What you need to know: interpreting hepatitis B viral markers.
Tan CK
Singapore Med J; 1998 Mar; 39(3):139-40. PubMed ID: 9632977
[No Abstract] [Full Text] [Related]
4. [Role of hepatitis B virus in the etiology of serologically silent viral hepatitis].
Emile JF
Gastroenterol Clin Biol; 1995 Oct; 19(10):856-7. PubMed ID: 8566575
[No Abstract] [Full Text] [Related]
5. [Hepatitis B virus: a better knowledge of its structure and variations in the expression of the viral disease].
Bréchot C
Gastroenterol Clin Biol; 1984; 8(8-9):641-5. PubMed ID: 6386590
[No Abstract] [Full Text] [Related]
6. [Hepatitis B virus in human pathology. I. Structural and antigenic analysis, hepadnaviridae, epidemiology, patho- and morphogenesis of hepatic lesions].
Aprosina ZG; Krel' PE
Klin Med (Mosk); 1989 Sep; 67(9):12-8. PubMed ID: 2685456
[No Abstract] [Full Text] [Related]
7. [Antigenic E system in hepatitis B virus-induced infection].
Kalinowska B
Pol Arch Med Wewn; 1978 Jun; 59(6):659-65. PubMed ID: 358161
[No Abstract] [Full Text] [Related]
8. [Occult hepatitis B infection].
Ergünay K
Mikrobiyol Bul; 2005 Apr; 39(2):241-9. PubMed ID: 16128037
[TBL] [Abstract][Full Text] [Related]
9. [Correlation between circulating HBV-DNA, HBcAb titers and post-transfusional hepatitis B].
Bedarida G; Cambiè G; D'Agostino F
Riv Emoter Immunoematol; 1984; 31(1):88-100. PubMed ID: 6531624
[No Abstract] [Full Text] [Related]
10. Occult hepatitis B virus infection among anti-HBc positive blood donors: Necessitates substitution of screening by HBV NAT.
Panhotra BR; Bahrani A; Joshi CS; ul Hassan Z
J Infect; 2005 Oct; 51(3):263. PubMed ID: 16125778
[No Abstract] [Full Text] [Related]
11. Hepatitis B virus and polyalbumin receptors.
Thung SN; Gerber MA
Prog Liver Dis; 1986; 8():335-45. PubMed ID: 3012639
[No Abstract] [Full Text] [Related]
12. Persistent hepatitis B virus infection in subjects without hepatitis B surface antigen: clinically significant or purely "occult"?
Bréchot C; Thiers V; Kremsdorf D; Nalpas B; Pol S; Paterlini-Bréchot P
Hepatology; 2001 Jul; 34(1):194-203. PubMed ID: 11431751
[No Abstract] [Full Text] [Related]
13. [Significance of "anti HBC alone" serological profile in 284 patients suspicious of being infected with hepatitis B virus].
Berrajah-Fki L; Ben Halima S; Guermazi F; Hammami A; Karray-Hakim H
Ann Biol Clin (Paris); 2006; 64(5):451-5. PubMed ID: 17040876
[TBL] [Abstract][Full Text] [Related]
14. Molecular and cellular pathology of hepatitis B.
Gerber MA; Thung SN
Lab Invest; 1985 Jun; 52(6):572-90. PubMed ID: 3892154
[No Abstract] [Full Text] [Related]
15. [Hepatitis B: serological strategy and epidemiological aspects].
Penna R; Rabagliati AM
G Batteriol Virol Immunol; 1981; 74(1-6):145-62. PubMed ID: 7030851
[No Abstract] [Full Text] [Related]
16. Recent developments in the diagnosis and monitoring of HBV infection and role of the genetic variability of the S gene.
Weber B
Expert Rev Mol Diagn; 2005 Jan; 5(1):75-91. PubMed ID: 15723594
[TBL] [Abstract][Full Text] [Related]
17. [Screening for hepatitis B].
Krogsgaard K
Ugeskr Laeger; 2002 Jan; 164(2):159-62. PubMed ID: 11831078
[No Abstract] [Full Text] [Related]
18. [The Public Health Council refines the selection process for (re)vaccination against hepatitis B].
Sekhuis J
Ned Tijdschr Geneeskd; 1987 Apr; 131(15):618-20. PubMed ID: 2952890
[No Abstract] [Full Text] [Related]
19. Correlation of hepatocyte expression of hepatitis B viral antigens with histological activity and viral titer in chronic hepatitis B virus infection: an immunohistochemical study.
Ramakrishna B; Mukhopadhya A; Kurian G
J Gastroenterol Hepatol; 2008 Nov; 23(11):1734-8. PubMed ID: 18713304
[TBL] [Abstract][Full Text] [Related]
20. Fulminant hepatitis B associated with a specific insertion in the basal core promoter region of hepatitis B virus DNA after immunosuppressive treatment.
Gérolami R; Henry M; Borentain P; Colson P; Botta D; Tamalet C
Clin Infect Dis; 2005 Feb; 40(4):e24-7. PubMed ID: 15712066
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
